Pharmacokinetic considerations for drugs administered in the critically ill

被引：6
|
作者：
Tansley, Gavin [1 ]
Hall, Richard [2 ]
机构：
[1] Dalhousie Univ, Dept Gen Surg, Halifax, NS B3H 3A7, Canada
[2] Dalhousie Univ, Dept Crit Care Med, Crit Care Med & Pharmacol, Halifax, NS B3H 3A7, Canada
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 2015年 / 76卷 / 02期
关键词：
RENAL REPLACEMENT THERAPY; PLASMA CREATININE CONCENTRATIONS; SYSTEMIC INFLAMMATORY RESPONSE; INTENSIVE-CARE-UNIT; PROTEIN-BINDING; P-GLYCOPROTEIN; POPULATION PHARMACOKINETICS; DISPLACEMENT INTERACTIONS; CLINICAL-RELEVANCE; CRITICAL ILLNESS;
D O I：
10.12968/hmed.2015.76.2.89
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Significant physiological changes are common among critically ill patients. This case-based review describes the consequences of these changes on the selection and dosing of medications.
引用
收藏
页码：89 / +
页数：6
相关论文
共 50 条
  • [21] Pharmacokinetic of oseltamivir in a critically ill patient with haemodialysis
    Verdier, M. C.
    Dolley-Hitze, T.
    Tribut, O.
    Marque, S.
    Alvarez, J. C.
    Bentue-Ferrer, D.
    Le Tulzo, Y.
    Bellissant, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 60 - 61
  • [22] Antiepileptic drugs in critically ill patients
    Farrokh, Salia
    Tahsili-Fahadan, Pouya
    Ritzl, Eva K.
    Lewin, John J., III
    Mirski, Marek A.
    CRITICAL CARE, 2018, 22
  • [23] Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
    Benitez-Cano, Adela
    Luque, Sonia
    Sorli, Luisa
    Carazo, Jesus
    Ramos, Isabel
    Campillo, Nuria
    Curull, Victor
    Sanchez-Font, Albert
    Vilaplana, Carles
    Horcajada, Juan P.
    Adalia, Ramon
    Bermejo, Silvia
    Samso, Enric
    Hope, William
    Grau, Santiago
    CRITICAL CARE, 2020, 24 (01):
  • [24] Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
    Adela Benítez-Cano
    Sonia Luque
    Luisa Sorlí
    Jesús Carazo
    Isabel Ramos
    Nuria Campillo
    Víctor Curull
    Albert Sánchez-Font
    Carles Vilaplana
    Juan P. Horcajada
    Ramón Adalia
    Silvia Bermejo
    Enric Samsó
    William Hope
    Santiago Grau
    Critical Care, 24
  • [25] Neuromuscular blocking drugs in the critically ill
    Welhengama, C.
    Hall, A.
    Hunter, J. M.
    BJA EDUCATION, 2021, 21 (07) : 258 - 263
  • [26] Antiepileptic drugs in critically ill patients
    Salia Farrokh
    Pouya Tahsili-Fahadan
    Eva K. Ritzl
    John J. Lewin
    Marek A. Mirski
    Critical Care, 22
  • [27] Neuromuscular blocking drugs in the critically ill
    Tripathi, S. S.
    Hunter, J. M.
    BJA EDUCATION, 2006, 6 (03) : 119 - 123
  • [28] Pharmacokinetics of orally administered melatonin in critically ill patients
    B Moroni
    G Mistraletti
    RJ Reiter
    R Esposti
    E D'Angelo
    P Formenti
    D Palmisano
    E Borotto
    P Di Mauro
    G Iapichino
    Critical Care, 14 (Suppl 1):
  • [29] Pharmacokinetics of orally administered melatonin in critically ill patients
    Mistraletti, Giovanni
    Sabbatini, Giovanni
    Taverna, Martina
    Figini, Maria Adele
    Umbrello, Michele
    Magni, Paolo
    Ruscica, Massimiliano
    Dozio, Elena
    Esposti, Roberto
    DeMartini, Germana
    Fraschini, Franco
    Rezzani, Rita
    Reiter, Russel J.
    Iapichino, Gaetano
    JOURNAL OF PINEAL RESEARCH, 2010, 48 (02) : 142 - 147
  • [30] THE CRITICALLY ILL SURGICAL PATIENT - NUTRITIONAL CONSIDERATIONS
    STARKER, PM
    GUMP, FE
    CRITICAL CARE CLINICS, 1987, 3 (01) : 205 - 216
12345